Agilon Health (NYSE:AGL) Stock Price Up 6.8% – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price traded up 6.8% during trading on Wednesday . The stock traded as high as $115.56 and last traded at $114.76. Approximately 101,823 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 350,864 shares. The stock had previously closed at $107.47.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. TD Cowen restated a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research note on Monday, May 4th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $80.00 price target (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $57.10.

Agilon Health Trading Up 3.1%

The stock’s 50 day simple moving average is $90.82 and its 200 day simple moving average is $43.37. The firm has a market cap of $1.92 billion, a PE ratio of -5.35 and a beta of 2.98. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. On average, sell-side analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of large investors have recently added to or reduced their stakes in AGL. LPL Financial LLC boosted its holdings in shares of Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares in the last quarter. Krilogy Financial LLC purchased a new position in shares of Agilon Health during the 4th quarter valued at about $34,000. CIBC Bancorp USA Inc. purchased a new position in shares of Agilon Health during the 3rd quarter valued at about $34,000. Merit Financial Group LLC bought a new stake in Agilon Health in the 4th quarter worth approximately $35,000. Finally, Focus Partners Advisor Solutions LLC bought a new stake in Agilon Health in the 4th quarter worth approximately $53,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.